Skip to content

Scientific Insights to Inform Discovery Decisions

Knowledge designed to support confident biologic discovery.

  • Mosaic Biosciences and Abkyu Partner to Expand VHH Discovery Capabilities

    Published: May 11, 2026 | Category: News, Partnerships Mosaic Biosciences and Abkyu have announced…
  • A New Approach to Long-Acting Intravitreal Biologics

    Published: April 27, 2026 | Category: Science, Ophthalmology, Protein Engineering Frequent intravitreal injections remain…
  • Your SBIR Award Budget Goes Further Than You Think

    Published: March 26, 2026 | Category: News, Technology, Biologics Discovery With SBIR and STTR…
  • Mosaic Biosciences Adds Carterra HT-SPR Platform to Accelerate Biologics Discovery

    Published: March 26, 2026 | Category: News, Technology, Biologics Discovery Mosaic Biosciences has expanded…
  • Ingenia Therapeutics tops current standard of care for degenerative retinal disease with modified bispecific antibody technology

    Optimizing a targeted bispecific antibody to improve expression and binding.
  • Why Developability Matters

    Optimizing a targeted bispecific antibody to improve expression and binding.
  • Festival of Biologics US

    Join the Mosaic team on March 4th and 5th in San Diego for FOB…
  • Solving Drug Discovery Challenges:

    Optimizing a targeted bispecific antibody to improve expression and binding.
  • Innovation in Sight: How Mosaic and Catalyst are Redefining Treatment for Dry AMD

    How Mosaic engineered a long-acting treatment for Geographic Atrophy, reducing patient injections to just…